Synthon Pharmaceuticals Inc
General
Total Cases35
Active Cases2
Patents18
Ratings
Experience
Grade
Trend
DCT
L2
E
PTAB
--
--
--
CAFC
--
--
--
Analytics
Cases
Litigated Patents
Ratings Trends
Recent Dockets
Entered | Case | Description |
|---|---|---|
| 01/30/24 | NOTICE OF FILING OF REDACTED EXHIBIT D TO AMENDED JOINT CASE STATUS REPORT AND REQUEST FOR STATUS CONFERENCE by SYNTHON B.V., SYNTHON INTERNATIONAL HOLDING B.V., SYNTHON PHARMACEUTICALS, INC. re 52 Memorandum Opinion and Order,, (Notice of filing of Redacted Exhibit D to Amended Joint Case Status Report) (Attachments: # 1 Exhibit 1 - Redacted Exhibit D to Amended Joint Case Status Report)(MORRIS, ROBERT) Modified to add text to title of document. on 1/31/2024 (at). (Entered: 01/30/2024) | |
| 01/30/24 | NOTICE OF FILING OF REDACTED EXHIBIT D TO AMENDED JOINT CASE STATUS REPORT AND REQUEST FOR STATUS CONFERENCE by SYNTHON B.V., SYNTHON INTERNATIONAL HOLDING B.V., SYNTHON PHARMACEUTICALS, INC. re 52 Memorandum Opinion and Order,, (Notice of filing of Redacted Exhibit D to Amended Joint Case Status Report) (Attachments: # 1 Exhibit 1 - Redacted Exhibit D to Amended Joint Case Status Report)(MORRIS, ROBERT) Modified to add text to title of document. on 1/31/2024 (at). (Entered: 01/30/2024) | |
| 01/23/24 | MEMORANDUM OPINION AND ORDER signed by JUDGE LORETTA C. BIGGS on 01/23/2024, that Plaintiffs' Motion to Seal, (ECF No. 46 ), is GRANTED. Specifically, the information that is redacted in the Amended Joint Case Status Report and Request for Status Conference, (ECF No. 45 ), shall remain under seal. FURTHER ORDERED that Defendants shall file an unsealed, redacted version of Exhibit D in accordance with this Memorandum Opinion, within 10 days of the publication of this Order, and the redacted information shall remain under seal. (at) (Main Document 52 replaced with correct pdf image on 1/23/2024) (at). Modified on 1/23/2024 (at). (Entered: 01/23/2024) | |
| 01/23/24 | MEMORANDUM OPINION AND ORDER signed by JUDGE LORETTA C. BIGGS on 01/23/2024, that Plaintiffs' Motion to Seal, (ECF No. 46 ), is GRANTED. Specifically, the information that is redacted in the Amended Joint Case Status Report and Request for Status Conference, (ECF No. 45 ), shall remain under seal. FURTHER ORDERED that Defendants shall file an unsealed, redacted version of Exhibit D in accordance with this Memorandum Opinion, within 10 days of the publication of this Order, and the redacted information shall remain under seal. (at) (Main Document 52 replaced with correct pdf image on 1/23/2024) (at). Modified on 1/23/2024 (at). (Entered: 01/23/2024) | |
| 12/22/23 | STIPULATION of Dismissal of Case (Corrected Signature Page) by SYNTHON B.V., SYNTHON INTERNATIONAL HOLDING B.V., SYNTHON PHARMACEUTICALS, INC.. (MORRIS, ROBERT) (Entered: 12/22/2023) | |
| 12/22/23 | STIPULATION of Dismissal of Case (Corrected Signature Page) by SYNTHON B.V., SYNTHON INTERNATIONAL HOLDING B.V., SYNTHON PHARMACEUTICALS, INC.. (MORRIS, ROBERT) (Entered: 12/22/2023) | |
| 12/22/23 | STIPULATION of Dismissal of Case by SYNTHON B.V., SYNTHON INTERNATIONAL HOLDING B.V., SYNTHON PHARMACEUTICALS, INC.. (MORRIS, ROBERT) (Entered: 12/22/2023) | |
| 12/22/23 | STIPULATION of Dismissal of Case by SYNTHON B.V., SYNTHON INTERNATIONAL HOLDING B.V., SYNTHON PHARMACEUTICALS, INC.. (MORRIS, ROBERT) (Entered: 12/22/2023) | |
| 12/15/23 | Case Reported Settled by Attorney Allison Mullins with the consent of all parties. Stipulation of Dismissal due by 1/16/2024. (glp) (Entered: 12/15/2023) | |
| 12/15/23 | Case Reported Settled by Attorney Allison Mullins with the consent of all parties. Stipulation of Dismissal due by 1/16/2024. (glp) (Entered: 12/15/2023) |